John L. Hays, MD, PhD, discusses unmet needs for patients with colorectal cancer and future directions for research in this disease.
John L. Hays, MD, PhD
Advertisement
Articles by John L. Hays, MD, PhD
John L. Hays, MD, PhD, discusses advances in treating patients with HER2-positive colorectal cancer.
John L. Hays, MD, PhD, discusses the importance of clinical trials in colorectal cancer.
John L. Hays, MD, PhD, discusses expanding treatment options for HER2-positive colorectal cancer.
John L. Hays, MD, PhD, discusses the importance of genetic testing in colorectal cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5